You are here: Industry Insights > vaccine development

News List

Coriolis Pharma Re-Establishes Chair in Vaccine Development at Leiden University B3C newswire
November 16, 2023
Coriolis Pharma Research today announced that the Special Chair in Vaccine Development at Leiden University has been re-awarded to Prof. Dr. Gideon Kersten, Scientific Advisor at Coriolis Pharma.
GeoVax Secures Multi-Product License for ProBioGen's AGE1.CR.pIX® Suspension Cell Line to Bolster MVA-Based Vaccine Development B3C newswire
November 06, 2023
ProBioGen and GeoVax Labs, announce the signing of a landmark commercial license agreement for ProBioGen's groundbreaking AGE1.
NEC OncoImmunity Acquires VAXIMM's Neoantigen Vaccine Development Assets PharmaSources.com
March 09, 2022
NEC OncoImmunity (NOI), a subsidiary of NEC Corporation (NEC), and VAXIMM AG, a Swiss/German biotech company focused on developing an oral plug and play DNA vaccination technology to stimulate patients' cytotoxic T-cells...
Hilleman Labs establishes Singapore's first pilot manufacturing facility for vaccine development CPhIonline
December 08, 2021
A 30,000-sq. ft cGMP facility and a separate R&D site will work alongside each other to provide end-to end product development solutions for Singapore and low- and middle-income countries
Everest Medicines and Providence Therapeutics Jointly Announce Vaccine Development Strategy to Address Omicron (B.1.1.529) SARS-CoV-2 Variant prnasia
December 01, 2021
Everest Medicines and Providence Therapeutics ("Providence") jointly announced today that the companies have started working on a new version of COVID-19 vaccine specifically targeting the new Omicron variant.
GenScript and BioComo Join Forces to Accelerate Novel Intranasal SARS-CoV-2 Vaccine Development in Japan prnasia
December 01, 2021
GenScript Biotech Corporation ("GenScript", Stock Code: 1548.HK), a leading global biotechnology company, and BioComo Incorporation, a drug discovery venture based in Mie prefecture, Japan...
Takeda and Frazier to launch HilleVax for norovirus vaccine development pharmaceutical-technology
August 02, 2021
Takeda Pharmaceutical and Frazier Healthcare Partners have partnered to launch a biopharmaceutical company named HilleVax to develop and market Takeda’s norovirus vaccine candidate, HIL-214 (previously TAK-214).
QPS Supports COVID-19 Vaccine Development In Taiwan, China prnewswire
August 02, 2021
QPS, a global contract research organization (CRO) focused on bioanalytics and clinical trials, is honored to have collaborated with Medigen Vaccine Biologics Corporation to complete toxicology studies necessary for the development of a COVID-19 vaccine.
NRx and Israel partner to advance Covid-19 vaccine development pharmaceutical-technology
July 13, 2021
NRx Pharmaceuticals has entered a memorandum of understanding with the Government of Israel to licence exclusive global development, manufacturing and commercialisation rights to a Covid-19 vaccine, BriLife.
mCureX and Samyang sign MoU for mRNA vaccine development pharmaceutical-technology
June 08, 2021
OliX Pharmaceuticals’ subsidiary mCureX has entered a memorandum of understanding (MoU) with Samyang Holdings to develop a messenger ribonucleic acid (mRNA) vaccine for Covid-19.